Advanced Enzyme Technologies Ltd

NSE: ADVENZYMES · BSE: 540025 · Pharmaceuticals & Biotechnology · 62 announcements

Share price: ₹271.60
Market cap: ₹3,041 Cr
Revenue (annual): ₹745.8 Cr
Net profit (annual): ₹168.7 Cr
P/E (TTM): 18.3×Sector 47.4×
Promoter holding: 43.24%-0.02% QoQ
FII holding: 26.70%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

8 Aug 2026 17:42 IST BSE

Advanced Enzyme Technologies Merger & Restructuring Worth ₹2 Cr

Advanced Enzyme Technologies is investing ₹2 Crore in its wholly-owned subsidiary, Advanced Nutrazyme Private Limited. This capital infusion supports the subsidiary's ongoing business operations.

Value: ₹2.00 Cr
Execution: 31-12-2027

Read the filing ↗

8 Aug 2026 17:42 IST BSE

Merger & Restructuring

Advanced Enzyme Technologies Merger & Restructuring Worth ₹7.98 Cr

Advanced Enzyme Technologies Limited will acquire the remaining 4.28% stake in JC Biotech Private Limited for ₹7.98 Crore, making it a wholly-owned subsidiary.

Value: ₹7.98 Cr

Read the filing ↗